6:19 PM
 | 
Jun 21, 2010
 |  BC Extra  |  Company News

FDA panel to discuss Revatio for pediatric PAH

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on July 29 to discuss whether or not to amend a clinical trial of Revatio sildenafil from

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >